Legal & General Group
INBX icon

Legal & General Group’s Inhibrx INBX Stock Holding History

Legal & General Group’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$337K Buy
5,009
+4,215
+531% +$313K ﹤0.01% 2452
2025
Q4 		$62.7K Buy
794
+26
+3% +$1.77K ﹤0.01% 2688
2025
Q3 		$25.9K Hold
768
– – ﹤0.01% 2937
2025
Q2 		$11K Sell
768
-277
-27% -$3.58K ﹤0.01% 3260
2025
Q1 		$14.6K Hold
1,045
– – ﹤0.01% 3055
2024
Q4 		$16.1K Hold
1,045
– – ﹤0.01% 3106
2024
Q3 		$16.4K Sell
1,045
-3,026
-74% -$42.5K ﹤0.01% 3129
2024
Q2 		$57.5K Buy
+4,071
New +$63.6K ﹤0.01% 2778

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Legal & General Group's INBX Position: Q1 2026 in Review

Legal & General Group increased its Inhibrx (INBX) stake by 531% in Q1 2026, buying an estimated $313K and bringing the position to 5,009 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #2452.

Legal & General Group first reported a position in INBX in Q2 2024 and has held it in 8 quarters since. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Legal & General Group held 5,009 shares of Inhibrx worth $337K as of Q1 2026.
  • Legal & General Group bought 4,215 Inhibrx shares in Q1 2026, an estimated $313K.
  • Inhibrx made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2452 holding.
  • Legal & General Group first reported a position in Inhibrx in Q2 2024 and has held it in 8 quarters since.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.